Infection prophylaxis

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Infections remain an important cause of non-relapse mortality in HSCT recipients. Specific risk for infection is related to prior exposure history (e.g., relapse of latent infection), intensity of conditioning regimens and immunosuppression, and new exposures in the setting of altered host immune response. Prevention of infection by prophylactic and preemptive strategies has been associated with improvement in transplant outcomes over the past few decades. The introduction of new oral antivirals (e.g., valganciclovir) and antifungal compounds (e.g., posaconazole, voriconazole) in the past decade has allowed for a less toxic and more facile approach to infection prevention.

Original languageEnglish (US)
Title of host publicationBlood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care
PublisherSpringer New York
Pages71-82
Number of pages12
ISBN (Print)9781441975058
DOIs
StatePublished - 2011

Fingerprint

Infection
Poisons
Immunosuppression
Antiviral Agents
History
Transplants
Recurrence
Mortality
valganciclovir
Voriconazole
posaconazole

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Strasfeld, L. (2011). Infection prophylaxis. In Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care (pp. 71-82). Springer New York. https://doi.org/10.1007/978-1-4419-7506-5_8

Infection prophylaxis. / Strasfeld, Lynne.

Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care. Springer New York, 2011. p. 71-82.

Research output: Chapter in Book/Report/Conference proceedingChapter

Strasfeld, L 2011, Infection prophylaxis. in Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care. Springer New York, pp. 71-82. https://doi.org/10.1007/978-1-4419-7506-5_8
Strasfeld L. Infection prophylaxis. In Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care. Springer New York. 2011. p. 71-82 https://doi.org/10.1007/978-1-4419-7506-5_8
Strasfeld, Lynne. / Infection prophylaxis. Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care. Springer New York, 2011. pp. 71-82
@inbook{5752ede8672e4c2ea55f73966e74de21,
title = "Infection prophylaxis",
abstract = "Infections remain an important cause of non-relapse mortality in HSCT recipients. Specific risk for infection is related to prior exposure history (e.g., relapse of latent infection), intensity of conditioning regimens and immunosuppression, and new exposures in the setting of altered host immune response. Prevention of infection by prophylactic and preemptive strategies has been associated with improvement in transplant outcomes over the past few decades. The introduction of new oral antivirals (e.g., valganciclovir) and antifungal compounds (e.g., posaconazole, voriconazole) in the past decade has allowed for a less toxic and more facile approach to infection prevention.",
author = "Lynne Strasfeld",
year = "2011",
doi = "10.1007/978-1-4419-7506-5_8",
language = "English (US)",
isbn = "9781441975058",
pages = "71--82",
booktitle = "Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care",
publisher = "Springer New York",

}

TY - CHAP

T1 - Infection prophylaxis

AU - Strasfeld, Lynne

PY - 2011

Y1 - 2011

N2 - Infections remain an important cause of non-relapse mortality in HSCT recipients. Specific risk for infection is related to prior exposure history (e.g., relapse of latent infection), intensity of conditioning regimens and immunosuppression, and new exposures in the setting of altered host immune response. Prevention of infection by prophylactic and preemptive strategies has been associated with improvement in transplant outcomes over the past few decades. The introduction of new oral antivirals (e.g., valganciclovir) and antifungal compounds (e.g., posaconazole, voriconazole) in the past decade has allowed for a less toxic and more facile approach to infection prevention.

AB - Infections remain an important cause of non-relapse mortality in HSCT recipients. Specific risk for infection is related to prior exposure history (e.g., relapse of latent infection), intensity of conditioning regimens and immunosuppression, and new exposures in the setting of altered host immune response. Prevention of infection by prophylactic and preemptive strategies has been associated with improvement in transplant outcomes over the past few decades. The introduction of new oral antivirals (e.g., valganciclovir) and antifungal compounds (e.g., posaconazole, voriconazole) in the past decade has allowed for a less toxic and more facile approach to infection prevention.

UR - http://www.scopus.com/inward/record.url?scp=84892204533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892204533&partnerID=8YFLogxK

U2 - 10.1007/978-1-4419-7506-5_8

DO - 10.1007/978-1-4419-7506-5_8

M3 - Chapter

SN - 9781441975058

SP - 71

EP - 82

BT - Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care

PB - Springer New York

ER -